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To the Editor: Blasberg and Groothuis ask why we did not discuss a particular set of published data on osmotic opening of the blood-brain barrier (BBB) in animals with brain tumors (Robinson and Rapoport, 1990) , namely the data of Hiesiger et al. (1986) using 1.37 M, equal to 1.6 molal, mannitol. Our publication was not a review of the literature, but rather an elaboration of a mathematical model involving parameters such as permeability at the J Cereb Blood Flow Metab, Vol. 11, No.1, 1991 BBB and blood-tumor barrier, and tissue diffusion, before and after osmotic opening. We chose only one experimental example to illustrate the princi ples of this model, and did not believe it necessary to also consider results with 1.37 M mannitol by Hiesiger et al. (1986) , our own data, nor many other published results. If they wish, Blasberg and Groothuis can easily apply our model to any results of special interest to them.
The suggestion of the Blasberg and Groothuis let ter is that carotid infusion of 1.37 M mannitol must produce the same barrier effects in all species and under all experimental conditions, and therefore that this solution is as ineffective in the clinic as it was in the rats studied by Hiesiger et al. (1986) . We disagree with their assumption, and the logic be hind it.
One reason is that infusate tonicity is not equiv alent to the tonicity to which the BBB at cerebral capillaries actually is exposed. Several factors, in cluding type of anesthetic, solution viscosity, and species differences in the diameter of the carotid vasculature, can influence infusate dilution by sys temic blood. The capillary concentration of infusate may be as little as one-half of the infusate concen tration during the osmotic procedure, as shown by experiments in which e4C]iodoantipyrine was in fused intravenously to measure cerebral blood flow during carotid infusion (Rapoport et aI., 1980) . Under standardized conditions with hypertonic arabinose in barbiturate-anesthetized rats, the max imum reversible osmotic opening of the BBB oc curs once a threshold tonicity is reached at a given infusion time, as illustrated in Fig. 1 (Rapoport et aI., 1980) . Thus, a 1.6 molal arabinose solution, in fused for 30 s into the carotid circulation, has the same BBB consequences as does a 1.8 molal solu tion, whereas a 1.4 molal solution is largely ineffec tive. At the capillary level, it is likely that arabinose concentrations are diluted but nevertheless propor tional to respective infusate concentrations.
The BBB effect of 1.37 M mannitol is maximal in rats anesthetized with phenobarbital, ketamine xylazine, isoflurane, methoxyflurane-phenyleph rine, or fentanyl-droperidol-propranolol (Gum erlock and Neuwelt, 1990) . However, animals anesthetized with methoxyflurane or fentanyldro peridol show a minimal opening, and are either more hypotensive or tachycardic than animals anes thetized with phenobarbital. It would appear that the capillary concentration of mannitol is reduced in the presence of each of these two anesthetics.
BBB opening with 1.6 molal arabinose in barbit urate-anesthetized rats is maximal and entirely re- Fig. 1) , with insignificant morbidity or mortality . Opening in the studies by Heisiger et al. (1986) frequently was fol lowed by death (1.6 M mannitol) or was not maxi mal (1.37 M mannitol), possibly because these stud ies changed the standard procedure of in two ways: (a) mannitol was substituted for arabinose, and (b) enflurane (starting with 9%, ending with 1-2%) and 70% nitrous oxide was sub stituted for pentobarbital as the anesthetic. Hypertonic mannitol is a very viscous solution, and requires higher perfusion pressures in the rat than does a less viscous arabinose solution. It is likely that it is distributed differently than hyper tonic arabinose between the carotid and systemic vasculatures. Furthermore, the use of enflurane nitrous oxide inhalation anesthesia, rather than a barbiturate, also may have reduced the BBB effec tiveness of 1.37 M mannitol, as does methoxyflu rane or fentanyl-droperidol anesthesia (see above), forcing Hiesiger et al. (1986) to raise the infusate concentration to 1.6 M, frequently lethal in their hands.
versible (
The above considerations suggest that 1.6 molal arabinose in barbiturate-anesthetized rats produced the same capillary threshold tonicity as did 1.6 M mannitol in the hands of Hiesiger et al. (1986) in rats anesthetized with enflurane-nitrous oxide. This in terpretation is supported by evidence that 1.4 M mannitol gives the same maximum BBB effect as does 1.8 and 2.0 M arabinose in barbiturate anesthetized rats (Neuwelt and Barnett, 1989) . These considerations led us to choose the 1.6 M mannitol data of Hiesiger et al. (1986) to illustrate our brain tumor model.
There is no information on the capillary concen tration of mannitol in brain-tumor patients infused with 1.37 M mannitol. In these patients, however, clinical imaging indicates substantial opening of the vasculature in brain and tumor (N euwelt et aI., 1980, 1987) . Quantitative permeability measure ments, if made available, could allow us to apply our model to these clinical studies.
We trust that the importance of osmotic threshold at the capillary site of the BBB, and of not equating infusate concentrations if anesthetics or species dif-fer, will lead Blasberg and Groothuis to reassess their comments.
